← FDA DRUG APPROVALS

FDA ANDA · ANDA074476

HYDROXYUREA

Sponsor: ROXANE

APPLICATION
ANDA074476
TYPE
ANDA
ORIGINAL APPROVAL
1995-08-18
LATEST ACTION
2001-12-12
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

HYDROXYUREADiscontinued
HYDROXYUREA 500MG · CAPSULE · ORAL

Approval history

2001-12-12Labeling · Supplement 6AP
2001-05-14Manufacturing (CMC) · Supplement 5AP
2000-05-31Manufacturing (CMC) · Supplement 2AP
2000-05-31Manufacturing (CMC) · Supplement 3AP
2000-05-31Labeling · Supplement 4AP
1997-11-20Labeling · Supplement 1AP
1995-08-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →